Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Postoperative Pain

Tanta UniversitySmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Postoperative Pain cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Tianjin Medical University General Hospital
Phase 4BBB
LIDOCAINE
Instituto Mexicano del Seguro Social
Phase 4BBB
NEPENTHE
IVO JURISIC
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
FENTANYL
IVO JURISIC
Phase 4BB

View all 39 →

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →